The overall incidental rate for neurodegenerative illnesses has risen in conjunction with the
aging population nowadays. Defects in beta-amyloid (Ab) and cholinergic system deposition …

Alzheimer's disease is a neurological disorder that results in cognitive and behavioral
impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs …

In recent years, the incidental rate of neurodegenerative disorders has increased
proportionately with the aging population. Alzheimer's disease (AD) is one of the most …

Alzheimer's disease (AD) is a multifarious progressive neuro-degenerative state among
elders. Potentiation of central cholinergic activity by using acetylcholinesterase inhibitors …

The presence of the blood–brain barrier becomes a formidable obstacle for Alzheimer's
disease (AD) drugs to enter the brain, usually leading to the failure of AD treatment …

Diseases that cause deterioration of the neurons are many and Alzheimer's disease (AD) is
a typical example. The prevalence of AD is increasing with a huge impact on the family …

As the globe's population increases, the incidences of Alzheimer's disease (AD) are steadily
increasing. AD represents the most common neurological disorder and constitutes 60–70 …

Alzheimer's disease (AD) is an attained disorder of cognitive and behavioral impingement
with progressive symptoms over time. It is mostly witnessed in elderly people, and as per the …

Alzheimer's disease (AD) is the most common neurodegenerative disease, and is part of a
massive and growing health care burden that is destroying the cognitive function of more …

The delivery of drugs to the brain is quite challenging in the treatment of the central nervous
system (CNS) diseases due to the blood-brain barrier and the blood-cerebrospinal fluid …